The Three Lichens: A Generalist Approach to Vulvar Skin Conditions

Authors

  • Emily Delpero, MD University of Ottawa, Ottawa, ON The Ottawa Hospital, Ottawa, ON Ottawa Health Research Institute, Ottawa, ON

DOI:

https://doi.org/10.58931/cwht.2024.1212

Abstract

Vulvar skin complaints represent a significant proportion of visits to family physician, dermatology and gynecology offices. Healthcare training programs place little emphasis on exposure to these conditions, which limits providers’ ability to assess and manage them. Increasing the visibility, recognition, and treatment of these conditions serves to improve patient care in Canada. 

Author Biography

Emily Delpero, MD, University of Ottawa, Ottawa, ON The Ottawa Hospital, Ottawa, ON Ottawa Health Research Institute, Ottawa, ON

Dr. Delpero completed her medical training at the University of Toronto including medical school, residency in Obstetrics and Gynecology, and fellowship in vulvovaginal health. During her training she also completed a certificate in health journalism through the Dalla Lana School of Public Health and the Munk School of Global Affairs, and obtained master’s in systems leadership and innovation through the Institute for Health Policy, Management and Evaluation. She is currently an assistant professor at the University of Ottawa, where she maintains a general obstetrics practice and a focussed gynecologic practice in vulvar skin disorders, colposcopy and menopause management.

References

Goldstein AT, Marinoff SC, Christopher K, et al. Prevalence of vulvar lichen sclerosus in a general gynecology practice. J Reprod Med. 2005;50(7):477-80.

Deo MS, Kerse N, Vandal AC, et al. Dermatological disease in the older age group: a crosssectional study in aged care facilities. BMJ Open. 2015;5(12):e009941.

Kreuter A, Kryvosheyeva Y, Terras S, et al. Association of autoimmune diseases with lichen sclerosus in 532 male and female patients. Acta Derm Venereol. 2013;93(2):238-41.

Krapf JM, Mitchell L, Holton MA, et al. Vulvar lichen sclerosus: current perspectives. Int J Womens Health. 2020;12:11-20.

Krapf JM, Smith AB, Cigna ST, Goldstein AT. Presenting Symptoms and Diagnosis of Vulvar Lichen Sclerosus in Premenopausal Women: A Cross-Sectional Study. J Low Genit Tract Dis. 2022;26(3):271-5.

Preti M, Joura E, Vieira-Baptista P, et al. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus Statements on Pre-invasive Vulvar Lesions. J Low Genit Tract Dis. 2022;26(3):229-44.

Lee A, Bradford J, Fischer G. Long-term management of adult vulvar lichen sclerosus: a prospective cohort study of 507 women. JAMA Dermatol. 2015;151(10):1061-7.

Lewis FM, Tatnall FM, Velangi SS, Bunker CB, Kumar A, Brackenbury F, et al. British Association of Dermatologists guidelines for the management of lichen sclerosus, 2018. Br J Dermatol. 2018;178(4):839-53.

Goldstein AT, Creasey A, Pfau R, et al. A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus. J Am Acad Dermatol. 2011;64(6):e99-104.

Khurana A, Tandon S, Marfatia YS, Madnani N. Genital lichen planus: An underrecognized entity. Indian J Sex Transm Dis AIDS. 2019;40(2):105-12.

Edwards L, Lynch PJ. Genital dermatology atlas and manual 3rd edition: Wolters Kluwer; 2018.

Vieira-Baptista P, Pérez-López FR, López-Baena MT, et al. Risk of development of vulvar cancer in women with lichen sclerosus or lichen planus: a systematic review. J Low Genit Tract Dis. 2022;26(3):250-7.

Sand FL, Thomsen SF. Skin diseases of the vulva: eczematous diseases and contact urticaria. J Obstet Gynaecol. 2018;38(3):295-300.

Ju T, Vander Does A, Mohsin N, Yosipovitch G. Lichen Simplex Chronicus Itch: An Update. Acta Derm Venereol. 2022;102:adv00796.

Delpero E, Sriharan A, Selk A. Steroid phobia in pataients with vulvar lichen sclerosus. J Low Genit Tract Dis. 2023;27(3):286-90.

Ladda M, Doiron P. Addressing topical corticosteroid phobia in atopic dermatitis: The role of the pharmacist. Can Pharm J (Ott). 2021;154(2):71-3.

Levin E, Gupta R, Butler D, et al. Topical steroid risk analysis: differentiating between physiologic and pathologic adrenal suppression. J Dermatolog Treat. 2014;25(6):501-6. Kamenov Z, Gateva A. Inositols in PCOS. Molecules. 2020 Nov 27;25(23):5566. doi: 10.3390/molecules25235566.

Downloads

Published

2024-06-25

How to Cite

Delpero, E. (2024). The Three Lichens: A Generalist Approach to Vulvar Skin Conditions. Canadian Women’s Health Today, 1(2), 18–22. https://doi.org/10.58931/cwht.2024.1212

Issue

Volume 1, Issue 2, Summer 2024

Section

Articles